Pathogenic mechanisms of exacerbated liver injury by exogenous insults in metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a systemic metabolic disorder that modifies the liver's response to acute injury. The presence of persistent metabolic stress, immune-inflammatory activation, organelle dysfunction, and impaired regenerative capacity collectively lower the threshold for acute hepatocellular injury (ALI) and hinder recovery. Consequently, individuals with MASLD exhibit heightened susceptibility to drug-induced liver injury (DILI), ischemia-reperfusion injury (IRI), and environmental toxins, resulting in more severe injury and a less favorable prognosis. This review examines ALI in MASLD, explores the mechanisms underlying increased susceptibility, and discusses how external factors exacerbate liver injury. It also summarizes key pathogenic mechanisms, proposes clinical management strategies, and identifies future research directions.

Authors

Institutions

Publication Details

Journal
Biochemistry and Biophysics Reports
Published
2026-11-20
DOI
https://doi.org/10.1016/j.bbrep.2026.102900
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pathogenic mechanisms of exacerbated liver injury by exogenous insults in metabolic dysfunction-associated steatotic liver disease

Xinfeng Sun, Rui Hu, Xiaozhou Zhou, Jing Li et al.
3 links
Biochemistry and Biophysics Reports
Liver Disease Diagnosis and Treatment
article

Pathogenic mechanisms of exacerbated liver injury by exogenous insults in metabolic dysfunction-associated steatotic liver disease

Xinfeng Sun, Rui Hu, Xiaozhou Zhou, Jing Li, Minling Lyu, Jialing Sun, Mengqing Ma, Qi Huang, Kongli Fan
article en

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a systemic metabolic disorder that modifies the liver's response to acute injury. The presence of persistent metabolic stress, immune-inflammatory activation, organelle dysfunction, and impaired regenerative capacity collectively lower the threshold for acute hepatocellular injury (ALI) and hinder recovery. Consequently, individuals with MASLD exhibit heightened susceptibility to drug-induced liver injury (DILI), ischemia-reperfusion injury (IRI), and environmental toxins, resulting in more severe injury and a less favorable prognosis. This review examines ALI in MASLD, explores the mechanisms underlying increased susceptibility, and discusses how external factors exacerbate liver injury. It also summarizes key pathogenic mechanisms, proposes clinical management strategies, and identifies future research directions.

Biochemistry and Biophysics ReportsVol. 48
Macau University of Science and Technology (MO), Guangzhou University of Chinese Medicine (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon